Status:
NOT_YET_RECRUITING
Efficacy of a Smartphone Suicide Prevention App
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Fondation FondaMental
Conditions:
Suicide
Suicide Attempt
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is an interventional research, single-blind, randomized, controlled, multicenter, which involves only minimal risks and constraints. Patients who attend to the emergency department following a SA ...
Detailed Description
632 participants will be enrolled and randomized into 2 groups: * Control group: 316 suicide attempters will benefit from the VigilanS program alone * Interventional group: 316 suicide attempters wil...
Eligibility Criteria
Inclusion
- Subject aged 18 or over
- Subject benefiting from the VigilanS program (after an admission to an emergency ward following a suicide attempt)
- Subject with his own smartphone (iOS/Androïd)
- Subject able to understand the nature, purpose and methodology of the study
- Subject must be covered by public health insurance
- Signed informed consent form
Exclusion
- Subject unable to read or/and write French
- Planned longer stay outside the region that prevents compliance with the visit plan
- Being protected by the law (tutorship or curatorship)
- Being deprived of liberty by administrative decision
- Being in a period of exclusion compared to another protocol
- Pregnant and breastfeeding women
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
632 Patients enrolled
Trial Details
Trial ID
NCT07160465
Start Date
September 1 2025
End Date
March 1 2028
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital
Montpellier, France, 34295